v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 65,114 $ 106,084
Short-term investments 200,290 264,984
Restricted cash 1,346 194
Accounts receivable 249 986
Prepaid expenses and other current assets 16,047 12,373
Total current assets 283,046 384,621
Property and equipment, net 7,270 53,780
Operating lease assets 70,834 26,159
Restricted cash - long-term 0 1,200
Other assets 7,166 2,367
Total assets 368,316 468,127
Current liabilities:    
Accounts payable 11,296 17,368
Accrued compensation 17,605 25,150
Accrued research and development expenses 17,868 13,451
Deferred revenue 2,662 40,760
Other current liabilities 22,813 9,057
Total current liabilities 72,244 105,786
Deferred revenue - long-term 42,338 55,708
Operating lease liabilities - long-term 61,072 25,518
Other long-term liabilities 5,549 1,501
Total liabilities 181,203 188,513
Commitments and contingencies (Note 10)
Stockholders’ equity:    
Common stock - $0.0001 par value, 500,000 shares authorized as of September 30, 2022 and December 31, 2021; 94,879 and 91,671 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 9 9
Additional paid-in capital 1,808,515 1,744,695
Accumulated other comprehensive (loss) income (2,959) (368)
Accumulated deficit (1,618,452) (1,464,722)
Total stockholders’ equity 187,113 279,614
Total liabilities and stockholders’ equity $ 368,316 $ 468,127

Source